Cost Effectiveness Analysis of Plasma Genotyping Versus Tumor Genotyping in Detection of Advanced Non-Small-Cell Lung Cancer With Epidermal Growth Factor Receptor and T790M Mutation Under the Brazilian Private Healthcare System Perspective

Jornal Brasileiro de Economia da Saúde
doi 10.21115/jbes.v10.n3.p262-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Jornal Brasileiro de Economia da Saude


Related search